4//SEC Filing
Williams Laura A 4
Accession 0001628280-25-041339
CIK 0001437402other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 7:30 PM ET
Size
10.3 KB
Accession
0001628280-25-041339
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Williams Laura A
Chief Patient Officer
Transactions
- Sale
Common Stock
2025-08-26$6.12/sh−50,000$306,050→ 396,322 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-08-26−50,000→ 112,000 totalExercise: $0.99Exp: 2032-01-06→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2025-08-26$0.99/sh+50,000$49,500→ 446,322 total - Sale
Common Stock
2025-08-26$6.12/sh−30,000$183,630→ 366,322 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades in prices ranging from $6.04 to $6.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F2]The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
ARDELYX, INC.
CIK 0001437402
Entity typeother
Related Parties
1- filerCIK 0001869194
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 7:30 PM ET
- Size
- 10.3 KB